Clinical Trials

ORBiT
(Optical Research for Biopsy Triaging)​

DynamX Medical have recently completed a Phase 2 in-clinic trial on oesophageal cancer and colon cancer.  This trial was performed at four independent sites across the UK.  

400 patient in-clinic trial, deploying the system bedside at 4 NHS endoscopy units, enabling us to validate clinical performance and ensure seamless integration with established clinical workflows.

System usability was tested over a wide range of users including research nurses, endoscopists and health care assistants.

Initial analysis of the study data shows improved performance over the previous Phase 1 clinical trial, enabling significant reduction in the workload for pathology services and expansion of screening programmes.

RADiCAL-Lung
  (RApid screening of buccal cells to Distinguish CAncer using Light)

DynamX Medical are working with Portsmouth NHS Trust on an Innovate UK funded programme to develop a non-invasive solution for early-stage screening and detection of lung cancer.

RADiCAL-Lung is aimed at screening and diagnosis of lung cancer, one of the most common and serious types of cancer.

Using a simple cheek swab, we are developing a reliable and non-invasive screening technique for early lung cancer detection.

RADiCAL-Lung will enable wide population screening for lung cancer, which usually has no signs or symptoms in the early stages.

© 2019 DynamX Medical is the trading name of BeamLine Diagnostics Ltd.
Registered in England & Wales Number 09504725.
Rutherford Appleton Laboratories, Atlas Building R27 Office F28, Harwell Campus, Didcot, OX11 0QX
Icons made by Freepik from www.flaticon.com